Year |
Citation |
Score |
2020 |
Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Woolford K, Franke J, Ramkumar V, Rybak L. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opinion On Drug Metabolism & Toxicology. PMID 32757852 DOI: 10.1080/17425255.2020.1806235 |
0.342 |
|
2019 |
Dhukhwa A, Bhatta P, Sheth S, Korrapati K, Tieu C, Mamillapalli C, Ramkumar V, Mukherjea D. Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss. Frontiers in Cellular Neuroscience. 13: 444. PMID 31632242 DOI: 10.3389/Fncel.2019.00444 |
0.327 |
|
2019 |
Sheth S, Sheehan K, Dhukhwa A, Al Aameri RFH, Mamillapalli C, Mukherjea D, Rybak LP, Ramkumar V. Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss. Scientific Reports. 9: 9571. PMID 31267026 DOI: 10.1038/S41598-019-45964-9 |
0.382 |
|
2019 |
Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention. Seminars in Hearing. 40: 197-204. PMID 31036996 DOI: 10.1055/S-0039-1684048 |
0.372 |
|
2019 |
Bhatta P, Dhukhwa A, Sheehan K, Al Aameri RFH, Borse V, Ghosh S, Sheth S, Mamillapalli C, Rybak L, Ramkumar V, Mukherjea D. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea. Scientific Reports. 9: 4131. PMID 30858408 DOI: 10.1038/S41598-019-40425-9 |
0.401 |
|
2018 |
Ghosh S, Sheth S, Sheehan K, Mukherjea D, Dhukhwa A, Borse V, Rybak LP, Ramkumar V. The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss. Frontiers in Cellular Neuroscience. 12: 271. PMID 30186120 DOI: 10.3389/Fncel.2018.00271 |
0.408 |
|
2017 |
Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Frontiers in Cellular Neuroscience. 11: 338. PMID 29163050 DOI: 10.3389/Fncel.2017.00338 |
0.394 |
|
2017 |
Borse V, Al Aameri RFH, Sheehan K, Sheth S, Kaur T, Mukherjea D, Tupal S, Lowy M, Ghosh S, Dhukhwa A, Bhatta P, Rybak LP, Ramkumar V. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death & Disease. 8: e2921. PMID 28703809 DOI: 10.1038/Cddis.2017.314 |
0.443 |
|
2017 |
Al Aameri RFH, Sheth S, Alanisi EMA, Borse V, Mukherjea D, Rybak LP, Ramkumar V. Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. Plos One. 12: e0177198. PMID 28467474 DOI: 10.1371/Journal.Pone.0177198 |
0.39 |
|
2016 |
Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D, Rybak LP, Ramkumar V. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 3962-77. PMID 27053204 DOI: 10.1523/Jneurosci.3111-15.2016 |
0.437 |
|
2014 |
Brito R, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. TRPV1: A Potential Drug Target for Treating Various Diseases. Cells. 3: 517-45. PMID 24861977 DOI: 10.3390/Cells3020517 |
0.314 |
|
2014 |
Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Adenosine receptors: expression, function and regulation. International Journal of Molecular Sciences. 15: 2024-52. PMID 24477263 DOI: 10.3390/Ijms15022024 |
0.343 |
|
2013 |
Jajoo S, Mukherjea D, Kaur T, Sheehan KE, Sheth S, Borse V, Rybak LP, Ramkumar V. Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer. Antioxidants & Redox Signaling. 19: 1863-76. PMID 23682737 DOI: 10.1089/Ars.2012.4820 |
0.36 |
|
2013 |
Sheth S, Jajoo S, Mukherjea D, Sheehan K, Rybak LP, Ramkumar V. Abstract 4084: Resveratrol attenuates prostate cancer growth by inhibiting insulin-like growth factor-1 receptor signaling. Cancer Research. 73: 4084-4084. DOI: 10.1158/1538-7445.Am2013-4084 |
0.358 |
|
2012 |
Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP, Ramkumar V. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. Plos One. 7: e51655. PMID 23272133 DOI: 10.1371/Journal.Pone.0051655 |
0.363 |
|
2012 |
Rybak LP, Mukherjea D, Jajoo S, Kaur T, Ramkumar V. siRNA-mediated knock-down of NOX3: therapy for hearing loss? Cellular and Molecular Life Sciences : Cmls. 69: 2429-34. PMID 22562580 DOI: 10.1007/S00018-012-1016-3 |
0.433 |
|
2012 |
Jajoo S, Kaur T, Mukherjea D, Sheehan K, Sheth S, Rybak LP, Ramkumar V. Abstract 1940: Anti-tumor action of adenosine A3 receptor in prostate cancer involves suppression of micro RNA-21 Cancer Research. 72: 1940-1940. DOI: 10.1158/1538-7445.Am2012-1940 |
0.345 |
|
2012 |
Sheth SB, Jajoo S, Mukherjea D, Kaur T, Sheehan K, Rybak L, Ramkumar V. Abstract 1093: Resveratrol inhibits prostate cancer metastasis by targeting microRNA-21 Cancer Research. 72: 1093-1093. DOI: 10.1158/1538-7445.Am2012-1093 |
0.362 |
|
2011 |
Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death & Disease. 2: e180. PMID 21776018 DOI: 10.1038/Cddis.2011.63 |
0.414 |
|
2011 |
Mukherjea D, Jajoo S, Sheehan K, Kaur T, Sheth S, Bunch J, Perro C, Rybak LP, Ramkumar V. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss. Antioxidants & Redox Signaling. 14: 999-1010. PMID 20712533 DOI: 10.1089/Ars.2010.3497 |
0.46 |
|
2011 |
Jajoo S, Mukherjea D, Sheehan K, Kaur T, Sheth S, Rybak LP, Ramkumar V. Abstract 1184: NADPH oxidase-dependent reactive oxygen species generation regulate micro RNA-21 in prostate cancer Cancer Research. 71: 1184-1184. DOI: 10.1158/1538-7445.Am2011-1184 |
0.346 |
|
2011 |
Sheth S, Jajoo S, Mukherjea D, Kaur T, Sheehan K, Ramkumar V. Abstract 1152: Micro RNA-21 serves as an essential target for resveratrol's anti-tumor action against metastatic prostate cancer cells Cancer Research. 71: 1152-1152. DOI: 10.1158/1538-7445.Am2011-1152 |
0.366 |
|
2010 |
Mukherjea D, Jajoo S, Kaur T, Sheehan KE, Ramkumar V, Rybak LP. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxidants & Redox Signaling. 13: 589-98. PMID 20214492 DOI: 10.1089/Ars.2010.3110 |
0.438 |
|
2010 |
Jajoo S, Mukherjea D, Kumar S, Sheth S, Kaur T, Rybak LP, Ramkumar V. Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery. American Journal of Physiology. Cell Physiology. 298: C56-65. PMID 19828838 DOI: 10.1152/Ajpcell.00190.2009 |
0.322 |
|
2009 |
Jajoo S, Mukherjea D, Watabe K, Ramkumar V. Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (New York, N.Y.). 11: 1132-45. PMID 19881949 DOI: 10.1593/Neo.09744 |
0.376 |
|
2008 |
Mukherjea D, Jajoo S, Whitworth C, Bunch JR, Turner JG, Rybak LP, Ramkumar V. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13056-65. PMID 19052196 DOI: 10.1523/Jneurosci.1307-08.2008 |
0.448 |
|
2008 |
Chang M, Mukherjea D, Gobble RM, Groesch KA, Torry RJ, Torry DS. Glial cell missing 1 regulates placental growth factor (PGF) gene transcription in human trophoblast. Biology of Reproduction. 78: 841-51. PMID 18160678 DOI: 10.1095/Biolreprod.107.065599 |
0.672 |
|
2007 |
Pingle SC, Jajoo S, Mukherjea D, Sniderhan LF, Jhaveri KA, Marcuzzi A, Rybak LP, Maggirwar SB, Ramkumar V. Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Molecular Pharmacology. 72: 856-67. PMID 17609415 DOI: 10.1124/Mol.106.031427 |
0.365 |
|
2007 |
Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hearing Research. 226: 157-67. PMID 17113254 DOI: 10.1016/J.Heares.2006.09.015 |
0.383 |
|
2006 |
Mukherjea D, Whitworth CA, Nandish S, Dunaway GA, Rybak LP, Ramkumar V. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin Neuroscience. 139: 733-740. PMID 16464536 DOI: 10.1016/J.Neuroscience.2005.12.044 |
0.329 |
|
2006 |
Jajoo S, Mukherjea D, Pingle S, Sekino Y, Ramkumar V. Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5'-diphosphate ribosylation-independent pathway. The Journal of Pharmacology and Experimental Therapeutics. 317: 1-10. PMID 16322354 DOI: 10.1124/Jpet.105.096255 |
0.383 |
|
2006 |
Chang M, Groesch K, Mukherjea D, Torry D. 1141584386 Cell type specific regulation of human placenta growth factor American Journal of Reproductive Immunology. 55: 403-404. DOI: 10.1111/J.1600-0897.2006.00383_31.X |
0.665 |
|
2005 |
Puntambekar P, Mukherjea D, Jajoo S, Ramkumar V. Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. Journal of Neurochemistry. 95: 1689-703. PMID 16283857 DOI: 10.1111/J.1471-4159.2005.03518.X |
0.408 |
|
2003 |
Torry DS, Mukherjea D, Arroyo J, Torry RJ. Expression and function of placenta growth factor: implications for abnormal placentation. Journal of the Society For Gynecologic Investigation. 10: 178-88. PMID 12759145 DOI: 10.1016/S1071-5576(03)00048-0 |
0.648 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Mukherjea D, Rybak LP, Sheehan KE, Kaur T, Ramkumar V, Jajoo S, Sheth S. The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert Opinion On Drug Discovery. 6: 491-505. PMID 22646075 DOI: 10.1517/17460441.2011.562887 |
0.299 |
|
2008 |
Jajoo S, Mukherjea D, Brewer GJ, Ramkumar V. Pertussis toxin B-oligomer suppresses human immunodeficiency virus-1 Tat-induced neuronal apoptosis through feedback inhibition of phospholipase C-beta by protein kinase C. Neuroscience. 151: 525-32. PMID 18093742 DOI: 10.1016/J.Neuroscience.2007.11.010 |
0.297 |
|
2021 |
Dhukhwa A, Al Aameri RFH, Sheth S, Mukherjea D, Rybak L, Ramkumar V. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss. Scientific Reports. 11: 8116. PMID 33854102 DOI: 10.1038/s41598-021-87387-5 |
0.295 |
|
2015 |
Mukherjea D, Ghosh S, Bhatta P, Sheth S, Tupal S, Borse V, Brozoski T, Sheehan KE, Rybak LP, Ramkumar V. Early investigational drugs for hearing loss. Expert Opinion On Investigational Drugs. 24: 201-17. PMID 25243609 DOI: 10.1517/13543784.2015.960076 |
0.283 |
|
2018 |
Sheehan K, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity. Journal of Visualized Experiments : Jove. PMID 29608150 DOI: 10.3791/56564 |
0.28 |
|
2009 |
Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. The Tohoku Journal of Experimental Medicine. 219: 177-86. PMID 19851045 DOI: 10.1620/Tjem.219.177 |
0.275 |
|
2011 |
Mukherjea D, Rybak LP. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics. 12: 1039-50. PMID 21787192 DOI: 10.2217/Pgs.11.48 |
0.272 |
|
2021 |
Ramkumar V, Mukherjea D, Dhukhwa A, Rybak LP. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity. Antioxidants (Basel, Switzerland). 10. PMID 34943021 DOI: 10.3390/antiox10121919 |
0.264 |
|
2019 |
Rybak LP, Dhukhwa A, Mukherjea D, Ramkumar V. Local Drug Delivery for Prevention of Hearing Loss. Frontiers in Cellular Neuroscience. 13: 300. PMID 31338024 DOI: 10.3389/Fncel.2019.00300 |
0.19 |
|
2021 |
Broderick MT, Prince ADP, Dhukhwa A, Mukherjea D, Jiang P, Campbell KCM, Rybak LP, Brenner MJ. Effects of Moringa Extract on Aminoglycoside-Induced Hair Cell Death and Organ of Corti Damage. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. PMID 34049329 DOI: 10.1097/MAO.0000000000003193 |
0.179 |
|
2021 |
Ramkumar V, Sheth S, Dhukhwa A, Al Aameri R, Rybak LP, Mukherjea D. Transient Receptor Potential (TRP) Channels and Auditory Functions. Antioxidants & Redox Signaling. PMID 34465184 DOI: 10.1089/ars.2021.0191 |
0.155 |
|
2015 |
Ramkumar V, Borse V, Ghosh S, Kaur T, Sheehan K, Sheth S, Dhukhwa A, Tupal S, Mukherjea D, Rybak LP. Role of adenosine receptors in auditory functions Adenosine Signaling Mechanisms: Pharmacology, Functions and Therapeutic Aspects. 183-192. |
0.129 |
|
2021 |
Rybak LP, Ramkumar V, Mukherjea D. Ototoxicity of Non-aminoglycoside Antibiotics. Frontiers in Neurology. 12: 652674. PMID 33767665 DOI: 10.3389/fneur.2021.652674 |
0.109 |
|
Hide low-probability matches. |